Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Reposted - may explain the large BID versus ASK
View:
Post by prone on Oct 05, 2024 8:42am

Reposted - may explain the large BID versus ASK

-->" I don't post garbage.  They are facts that Pfizer and USC Keck have been working together since 2013 and Pfizer has exclusive option to start clinical trials on anything promising.   

Then Medipharm joined the picture in 2015.   
In 2023 Medipharm shipped clinical trial material to USC Keck with approval by the DEA and funded by the NIH.   

But what I see is there are a handful of people on this board who think they run it and want to control the narrative and keep things in a negative tone by 'bashing' other posters.   
 
I'm still very optimistic that this company will show profits in October reporting and maybe a reason why they suddenly payed off the last piece of debt.   
 
If you have facts to bring to this forum then that's great but don't bash other people because it makes you look desperate instead of fact based investor. " 
Comment by Solid1 on Oct 05, 2024 8:50am
Where can you see that Pfizer has any exclusive rights to research and studies? There must be some news about this 
Comment by newbie101abc on Oct 05, 2024 10:44am
That is simple.  It is in the research agreement between USC Keck and Pfizer, including regulatory support and clinical trial support.   The NIH and especially the CDC are in a full blown panic unless you've been living in a cave and not realizing all of the viruses spreading around the globe.  Be it mpox, warburg in Africa, swine fever putting Italy's $30 billion CAD ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse